MitoVitE, a mitochondria-targeted antioxidant, limits paclitaxel-induced oxidative stress and mitochondrial damage in vitro, and paclitaxel-induced mechanical hypersensitivity in a rat pain model

McCormick, BLowes, D AColvin, LTorsney, CGalley, H F2017-11-022017-11-022016-11-30McCormick, B, Lowes, D A, Colvin, L, Torsney, C & Galley, H F 2016, 'MitoVitE, a mitochondria-targeted antioxidant, limits paclitaxel-induced oxidative stress and mitochondrial damage in vitro, and paclitaxel-induced mechanical hypersensitivity in a rat pain model', British Journal of Anaesthesia, vol. 117, no. 5, pp. 659-666. https://doi.org/10.1093/bja/aew3090007-0912http://hdl.handle.net/2164/9554The study was funded by the Association of Anaesthetists of Great Britain and Ireland, the British Journal of Anaesthesia/Royal College of Anaesthetists (PhD studentship award to BM) and the Melville Trust.8651305171605engSDG 3 - Good Health and Well-beingpainpaclitaxelmitochondriaR MedicineRMitoVitE, a mitochondria-targeted antioxidant, limits paclitaxel-induced oxidative stress and mitochondrial damage in vitro, and paclitaxel-induced mechanical hypersensitivity in a rat pain modelJournal article10.1093/bja/aew3091175